Skip to content

Beam Therapeutics

US · BEAM #2614 by market cap Listed 2020
24.77 -0.46 -1.82%
Live - 5344 symbols - heartbeat 83s ago · 2026-10-08 07:00
Pre-market 24.70 -0.28%
After-hours 25.00 +0.91%
Overnight 24.72 -0.20%
Market cap
2.56B
P/B
2.40
EPS
-0.81
Reader sentiment Are you bullish or bearish on BEAM?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
  • Total institutional ownership fell 4.3 percentage points.

Institutional ownership

Held by institutions
106.66% -4.33pp
Institutions
337 -1
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund73.43%
Hedge Fund18.62%
VC/PE Fund8.43%
Public Company3.52%
Private Company1.89%
Individual/Insider1.36%
Government Pension Fund0.36%
Family Office/Trust0.28%
Insurance Company0.13%

Top holders

FMR 11.76%
Farallon Capital Management, L.L.C. 10.24%
ARK Investment Management LLC 10.24%
BlackRock 9.00%
State Street Global Advisors 5.83%
Vanguard Capital Management, LLC 5.31%
Vanguard Portfolio Management, LLC 4.92%
Arch Venture Partners, L.P. 4.54%
Amova Asset Management 3.46%
T. Rowe Price Group, Inc. 3.42%

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 20 buys · 30 sells

NameRoleStake
FMR -- 11.76%
John Evans Chief Executive Officer 0.95%
Giuseppe Ciaramella President 0.17%
Christine Bellon Chief Legal Officer 0.11%
Robert Taylor Nelsen Former Independent Director 0.06%
Mark Fishman Independent Director 0.02%
Bethany Cavanagh Senior VP of Finance & Treasurer 0.01%
Sravan Emany Chief Financial Officer 0.01%
Amy Simon Chief Medical Officer 0.00%
John Michael Maraganore Independent Director --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-30 Bethany Cavanagh Senior VP of Finance & Treasurer Automatic Disposition -187 $24.41
2026-09-23 Giuseppe Ciaramella President Other Disposition -123,407 --
2026-07-26 Amy Simon Chief Medical Officer Automatic Disposition -16,667 $25.74
2026-06-29 John Evans Chief Executive Officer Derivative Exercise and Sale -50,000 $0.67–35.91
2026-06-29 John Evans Chief Executive Officer Intent to Sell (Form 144) -25,000 $34.31
2026-06-29 Amy Simon Chief Medical Officer Automatic Disposition -373 $34.73
2026-06-28 John Evans Chief Executive Officer Intent to Sell (Form 144) -25,000 $35.49
2026-06-16 Giuseppe Ciaramella President Derivative Exercise and Retained +35,505 $0.67–1.03
2026-06-02 John Michael Maraganore Independent Director Other Derivative Acquisition +19,676 $29.55
2026-06-02 Mark Fishman Independent Director Other Derivative Acquisition +19,676 $29.55
2026-06-02 Graham Cooper Independent Director Other Derivative Acquisition +19,676 $29.55
2026-06-02 Kathleen Walsh Independent Director Other Derivative Acquisition +19,676 $29.55
2026-06-02 Chirfi Guindo Director Other Derivative Acquisition +19,676 $29.55
2026-06-02 Christi Shaw Director Other Derivative Acquisition +19,676 $29.55
2026-04-13 Carole Ho Independent Director Intent to Sell (Form 144) -87,784 $30.73
2026-04-01 Christine Bellon Chief Legal Officer Intent to Sell (Form 144) -20,000 $21.90
2026-04-01 John Evans Chief Executive Officer Intent to Sell (Form 144) -66,874 $21.90
2026-04-01 Giuseppe Ciaramella President Intent to Sell (Form 144) -26,250 $21.90
2026-04-01 Amy Simon Chief Medical Officer Intent to Sell (Form 144) -20,000 $21.90
2026-03-31 Christine Bellon Chief Legal Officer Automatic Disposition -5,956 $24.58

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 07:00:14 · For reference only, not investment advice and not tailored to your situation.